// App-Quantinova.ai

e17042 : Modeling tumor size time course in platinum resistant/refractory ovarian cancer patients treated with vanucizumab.

Researchers

Presenter

  • Christophe Boetsch

Principal Investigators

  • Kevin Smart

  • Benjamin Ribba

  • Francois Mercier

  • Oliver Krieter

  • Vincent Buchheit

  • Angelika Lahr

  • Alex Phipps

Medical Centers

  • Roche Innovation Center Basel, Basel, Switzerland

  • Roche Products Ltd., Welwyn Garden City, United Kingdom

  • F. Hoffmann-La Roche Ltd., Basel, Switzerland

  • Roche Innovation Center, Penzberg, Germany

Locations

  • Germany

  • Switzerland

  • United Kingdom

Companies

  • F. Hoffmann-La Roche

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Genetic Disorder

Disease

  • Gynaecological cancer

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • NCT01688206

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved